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ABSTRACT 
Background & Aims: Risk factors for cardiovascular disease, such as obesity and hypertension, 
have been associated with non-alcoholic fatty liver disease. Psychological distress (symptoms of 
anxiety and depression) is a risk factor for cardiovascular disease, so it might also be associated, 
directly or indirectly, with elevated rates of liver disease. We investigated the relation of 
psychological distress (measured by the 12-item General Health Questionnaire; GHQ) with liver 
disease mortality.  
 
Methods: We performed a meta-analysis of data from individual participants in 16 prospective 
studies of the general population of the UK, initiated from 1994 through 2008. We categorized 
GHQ score into four groups: zero (no distress), 1-3, 4-6, and 7-12. 
 
Results: We used data from 166,631 individuals (55% women; age, 46.6±18.4 years; range, 
16−102 years). During a mean follow-up period of 9.5 years, 17,368 participants died (457 with 
liver disease). We found a significant increase in risk for liver disease mortality as GHQ score 
increased across categories (ptrend<0.001). The age- and sex-adjusted hazard ratio for the highest 
GHQ category (7-12) compared to those scoring zero was 3.48 (95% confidence interval, 
2.68−4.52). After adjustment for health behaviors, socioeconomic status, body mass index, and 
diabetes, the hazard ratio was partially attenuated to 2.59 (95% confidence interval, 1.82–3.68). 
 
Conclusions: Our novel finding that psychological distress was associated with liver disease 
mortality requires testing in other studies. Though results are unlikely to be causal, we provide 
further evidence for the deleterious effects of psychological problems on physical health.  
 
KEYWORDS: death, steatosis, cirrhosis, mental health, GHQ-12 
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INTRODUCTION 
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic 
syndrome. With an ageing and increasingly obese and diabetic population,1, 2 the prevalence of 
NAFLD is rising. Current estimates suggest the prevalence in the general population to be 
around one third,3 rising in high risk populations (e.g., those with type 2 diabetes mellitus) to as 
high as 70%.4, 5 The spectrum of NAFLD extends from simple steatosis, through steatohepatitis 
(NASH) and fibrosis to cirrhosis and its complications (liver failure, hepatocellular carcinoma 
and gastro-oesophageal varices). Already NAFLD as a primary cause represents the third 
commonest indication for liver transplantation in the USA (8.5%).6  
 
With no disease-specific therapy, treatment for early NAFLD centres on weight management 
through lifestyle modification and, for later disease, surveillance for complications.7, 8 Given such 
limited treatments, it is imperative to develop strategies to identify high risk individuals prior to 
their developing significant disease and also to identify potentially modifiable risk factors.  
 
There is growing evidence of links between NAFLD and cardiovascular disease (CVD). Several 
population-based studies have identified higher rates of CVD in NAFLD population compared 
to the general population.9, 10 The NAFLD and CVD association is biologically plausible given 
their shared causal pathways – dyslipidaemia, systemic inflammation and insulin resistance. The 
atherogenic liver theory (the liver-vessel axis hypothesis) is a further connection.11  
 
It is also the case that psychological distress (anxiety and depression) is becoming recognized as a 
risk factor for CVD.12-16 That liver disease has, at least in part, a shared aetiology with CVD raises 
the suggestion of a predictive role for psychological distress in the occurrence of liver disease. 
Possible mechanisms include an indirect association via health behaviours including alcohol 
intake, tobacco use and poor diet. Psychological distress might also be linked to liver disease 
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through stress-induced dysregulation of the hypothalamic-pituitary-adrenal axis resulting in the 
hepatic release of pro-inflammatory factors (e.g. interleukin-6, tumour necrosis factor alpha)17 
ultimately leading to the development of NAFLD.18  
 
Despite a plausible prima facie case for a link between distress and liver disease, to the best of our 
knowledge, it has yet to be tested. Therefore, we examined the association between distress and 
liver disease risk by pooling raw data from 16 cohort studies in an individual participant meta-
analysis. In contrast to the more traditional literature-based meta-analysis in which investigators 
may have to exclude publications that do not present results in a standard manner, the possibility 
of publication bias is reduced in an individual participant meta-analysis. Additionally, a literature 
based meta-analysis cannot provide a consistent approach to statistical control for plausible 
covariates.  
 
METHODS 
Study samples 
Participants were drawn from representative, general population-based health examination 
studies sampling household-dwelling individuals living in the United Kingdom: 13 Health 
Surveys for England19 (conducted annually between 1994 and 2008) and three Scottish Health 
Surveys20 (conducted in 1995, 1998, and 2003). Consenting study members were linked to 
National Health Service mortality records up to the first quarter of 2011. For these analyses, raw 
data for all these study years were used, with the exception of Health Surveys for England from 
1996 and 2007 when psychological distress was not measured. Ethical approval was obtained 
from the London Research Ethics Council. 
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Measurement of psychological distress 
During a household visit, interviewers collected information using computer-assisted personal 
interviewing modules. Psychological distress was measured using the 12-item version of the 
General Health Questionnaire (GHQ-12), a widely-used measure of distress in population 
studies.21, 22 The GHQ-12 is generally considered to be a unidimensional scale of psychological 
distress,23 consisting of items capturing symptoms of anxiety, depression, social dysfunction, and 
loss of confidence. Study members respond using a four-point Likert scale (symptom present: 
'not at all' or 'same as usual' scored zero; 'more than usual' or 'much more than usual' scored one 
point). A total GHQ-12 score of four or greater leads to individuals being defined as suffering 
from psychological distress and scores less than four are not considered to indicate substantial 
distress; this definition has been validated against standardised psychiatric interviews and has 
been strongly associated with various psychological disorders such as depression and anxiety.24, 25 
Most previous studies of psychological distress have used such a dichotomy and few have 
examined associations across the full range of psychological distress. There are no standard cut-
offs for further sub-dividing the group of people identified as suffering from psychological 
distress by a GHQ-12 score threshold. We therefore chose to divide individuals into four groups 
based on GHQ-12 score: asymptomatic (GHQ-12 score zero), sub-clinically symptomatic 
(GHQ-12 score 1-3), symptomatic (GHQ-12 score 4-6), and highly symptomatic individuals 
(GHQ-12 score 7-12). This is the approach we have taken in previous analyses.16, 26, 27 
 
Measurement of collateral data 
Alcohol consumption (units per week), smoking status (not a current smoker; or <5, 5-10, 10-15, 
15-20, and >20 cigarettes per day), age upon leaving full-time education, current occupational 
social class (professional, managerial or technical, skilled non-manual, skilled manual, partly 
skilled, and unskilled), and body mass index (based on directly measured height and weight) were 
ascertained during the interview using standard protocols.19, 20 
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Where available, additional data recorded were presence of diabetes mellitus at baseline (defined 
as one or more of the following indicators: self-reported doctor-diagnosed diabetes mellitus, 
responding affirmatively to having a longstanding illness and identifying it as diabetes mellitus, 
diabetes mellitus hospitalisation, and serum HbA1c level),
28 number of weekly episodes of 
moderate to vigorous physical activity including domestic,29 and use of antihypertensive 
medication. Physical examination was undertaken by a nurse at a subsequent home visit and 
included systolic and diastolic blood pressure. Venous blood was also drawn to measure serum 
gammaglutamyl transferase (gamma-GT) level, serum cholesterol (total and HDL-cholesterol), 
and serum C-reactive protein. All serum measurements were undertaken at the time of the 
second survey visit and analysed at local NHS hospital laboratories using standard protocols.  
 
Mortality data 
Vital status and, where applicable, causes of death were ascertained via linkage with national 
mortality records. All causes of death recorded on death certificates were coded using the 
International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions. Liver disease 
deaths were identified and categorised using the following ICD codes (a modification of a 
previous approach30): alcoholic liver disease (ICD-9 571.0-571.3; ICD-10 K70), viral hepatitis 
(070; B15-B18); neoplastic disease (155; C22); fatty liver disease (571.8; K76.0); other liver 
disease diagnoses (006.3, 275.0, 571.6, 572.0, 572.1; A06.4, E83.1, K71, K74.3, K75.0, K77.0, 
K77.8); and other non-specific liver disease (456, 570, 571.4, 571.5, 571.9, 572.2-572.8, 573; K72, 
K73, K74 [not K47.3], K75 [not K75.0], K76 [not K76.0], I98.2-3). Two liver disease mortality 
sub-categories were defined: alcoholic liver disease (defined as any mention on the death 
certificate) and probable NAFLD (defined as any mention of fatty or other non-specific liver 
disease but no mention of alcoholic liver disease, viral hepatitis, neoplastic disease, or other liver 
disease diagnosis). 
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Statistical analyses 
Preliminary analyses showed no evidence of effect modification by gender (p=0.52) so data from 
men and women were pooled. After ascertaining that the proportional hazards assumption had 
not been violated, we used Cox proportional hazards models31 to compute study-specific hazard 
ratios (HR) with accompanying 95% confidence intervals (CI) for the association of GHQ-12 
score with liver mortality. We pooled the study-specific effect estimates and their standard errors 
in random effects meta-analyses in order to preserve within-study variation. Study members 
scoring zero on the GHQ-12 were regarded as being free of psychological distress and used as 
the reference group. In these analyses, we used four categories of psychological distress in order 
to allow us to explore dose-response associations. The group scoring zero was compared to the 
three groupings by GHQ-12 score mentioned above (1-3, 4-6, and 7-12) as well as the hazard 
ratio per one standard deviation increment (disadvantage) in GHQ-12 score (calculated with sex-
specific standard deviations) being reported. Calendar time (months) was the time scale and, for 
participants with no record of an event, the data were censored at the first quarter of 2011. 
Models were adjusted for age (years), sex, health behaviours (frequency of alcohol consumption 
and smoking), socioeconomic status (age upon leaving full-time education and occupational 
social class), body mass index and diabetes mellitus. The primary outcome was all liver-related 
mortality. Secondary analyses examined (i) models including only individuals who did not 
consume alcohol or who had a normal BMI, (ii) additional covariates that had been measured 
only in specific years (physical activity, systemic arterial hypertension, gamma-GT, serum 
cholesterol, non-HDL cholesterol, C-reactive protein), and (iii) liver disease sub-categories: 
alcoholic liver disease and probable NAFLD. Details on the measurement protocols and data 
handling of these covariates can be found elsewhere.19, 20 Finally, we conducted two sensitivity 
analyses: (i) repeating the age- and sex- adjusted models including only individuals with complete 
data for all variables included in the multivariable models; and (ii) examining the effect of reverse 
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causality by dropping deaths occurring in the first five years of follow up. All analyses were 
conducted using R version 2.15.232 and the survival and metafor33 packages. 
 
RESULTS 
Study member characteristics according to each of the sixteen studies featured in this pooling 
project are given in table 1. There was some evidence of the expected secular changes in selected 
characteristics, such that the proportion of study members leaving school after the compulsory 
school leaving age and mean body mass index increased while survey response declined. There 
was no change in psychological distress score across the studies.  
 
In figure 1 we show the flow of participants from study induction through to analyses. After 
removing 32,873 participants (16.5%) who declined to be linked to mortality records and those 
who were missing psychological distress data, the analytic sample comprised 166,631 people 
(54.9% women; mean±SD age 46.6±18.4 years; range 16-102). On comparing the characteristics 
of the analytical sample with study members who had been excluded (table 2), we found that, 
owing to the high numbers in the analyses, while absolute differences between the groups were 
very small, statistical significance at conventional levels was apparent. Thus, the exclusion of 
individuals from the present analyses is unlikely to have led to substantial selection bias. Indeed, 
we have previously examined this issue in another study and found no evidence that the relation 
of distress to both total mortality and cardiovascular disease mortality differed according to 
whether participants agreed to respond to a resurvey questionnaire or not.34 
 
Based on the 166,631 study members in the analytical sample, we examined baseline covariates 
according to categories of psychological distress (table 3). Relative to people with lower distress 
levels, those who had higher scores were more likely to be female, have a basic education, to 
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smoke, to be obese, and to have diabetes mellitus. Weekly intake of alcoholic beverages was less 
frequent in people reporting higher levels of distress. 
  
A mean (SD) follow up of 9.5 (4.3) years across the sixteen studies gave rise to 17,368 deaths, 457 
of which were ascribed to liver disease. In supplementary figure 1 we depict the relation between 
psychological distress and liver disease mortality according to each study in the present meta-
analysis. A standard deviation increase in distress score was almost invariably associated with an 
increased rate of liver disease mortality – exceptions were the HSE in 1997, 1999, and 2000 – 
although statistical significance was not always apparent. This pattern of effect was highly 
consistent between studies as evident from the I2 statistics which indicate low heterogeneity. 
Taking the sixteen studies in aggregate, higher levels of distress were associated with a 26% 
greater risk of total liver disease mortality in multivariable-adjusted analyses. 
 
Psychological distress was associated with increased liver disease mortality rates in age- and 
gender adjusted models (hazard ratio per standard deviation increase in GHQ-12 score: 1.40; 
95% confidence interval 1.31-1.50), effects that were only marginally attenuated on full 
adjustment (1.26; 1.13-1.40; table 4). Individuals with high levels of psychological distress (GHQ-
12 score 7-12) were at substantially raised risk of liver disease mortality (multivariable-adjusted 
HR 2.59; 95% CI 1.82-3.68) compared to those scoring zero on the GHQ-12. Disaggregating the 
distress categories further in order to explore the shape of the relation with liver disease resulted 
in a suggestion of a dose-response pattern (Figure 2).  
 
Models including only individuals who did not consume alcohol or who had a normal BMI 
showed similar findings (table 5). We also repeated the analyses for the sub-categories of 
alcoholic liver disease and probable NAFLD which yielded similar results (supplementary tables 1 
and 2 and supplementary figure 2), though the association was steeper for probable NAFLD. 
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Finally, we carried out the planned sub-group analyses including additional covariates and 
sensitivity analyses examining the effects of missing data and reverse causality: the strength of the 
distress-liver disease mortality relation was essentially unchanged (table 4 and supplementary table 
3).  
 
DISCUSSION 
To our knowledge, this is the first population-based study to examine the association between 
psychological distress and liver disease related mortality. In this large, general population sample 
we found evidence of a dose-response relationship between increasing psychological distress (as 
measured by the GHQ-12) and increasing liver disease-related mortality that was not completely 
explained by health behaviours (including alcohol consumption), diabetes mellitus, 
socioeconomic status, body mass index or inflammation. Indeed, the magnitude of the observed 
hazard ratios at higher levels of distress (multivariable adjusted HR 2.59, 95% CI 1.82-3.68) is 
high by the standards of modern epidemiology, where the majority of HRs reported range from 
one to two. Included within our analyses, we took into account the well-established observation 
of an unfavourable risk factor profile in people experiencing psychological distress, in particular 
their higher prevalence of smoking and physical inactivity. Given the novelty of the distress-liver 
disease results, we also examined if established risk factors for liver disease were shown in the 
present dataset. As anticipated, obesity (age- and sex-adjusted HR, 95% CI: 1.28, 0.97-1.70), 
diabetes (2.83, 1.83-4.41), and hypertension (1.94, 1.45-2.59) were all related to liver disease 
mortality. This gives us some confidence in the more novel results for psychological distress.  
 
Plausible mechanisms 
Whilst this type of study is not able to confirm direct cause and effect it can provide insights into 
relationships warranting further consideration. Indeed, a direct effect seems unlikely. The 
distress-liver disease relation was not fully explained by existing covariates in the present study, 
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including alcohol consumption, smoking, socioeconomic status, body mass index, and diabetes 
mellitus. This suggests that other mechanisms underlying this association exist. It is possible that 
extant but hidden liver disease at baseline was associated with psychological distress and 
subsequent mortality. However, repeating the multivariable models dropping deaths occurring in 
the first five years of follow up did not alter our conclusions, suggesting that reverse causality did 
not materially bias our findings. 
 
In an attempt to look more closely at potential risk factors our subgroup analyses examined 
additional covariates (physical activity, systemic arterial hypertension, serum gamma-GT, serum 
cholesterol, and serum C-reactive protein). Furthermore, different liver diseases have markedly 
different underlying pathologies and so we examined sub-categories of liver disease. In our study 
we were able to attribute 40% of liver related deaths to probable NAFLD and 38% to alcoholic 
liver disease, i.e. together these diseases constituted the majority of the sample. For these two 
groups there were stronger relationships with psychological distress than with all liver disease 
related deaths combined. Both NAFLD and alcoholic liver disease result in similar pathological 
changes in the liver, and both feature systemic inflammation as a prominent feature.35, 36 Given 
the argument of systemic inflammation as a shared risk factor between psychological distress and 
NAFLD we would have expected to see the statistical relationship markedly attenuated after 
adjustment for C-reactive protein, however this was not the case in the sub-group analysis. In 
addition, adjustment for factors related to CVD had only a small effect. This suggests that there 
is a mechanism at work beyond those we were able to study. Examples might include 
dysregulation of iron deposition or other trace elements (e.g. copper) or other ‘toxins’ that are 
detrimental to both brain and liver.37, 38 Indeed, raised serum transferrin saturation and greater 
dietary iron consumption has been linked to increased mortality.39 In addition to the possibility 
of a causal relationship between psychological distress and liver disease, there is the possibility of 
a common cause; that is, factors that drive psychological distress may also drive liver disease. 
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Strengths and Limitations 
This study used a very large sample of the general population, and over 17,000 participants died 
during follow-up, over 450 with liver disease related. This large sample size allows detailed 
analyses to be conducted and the pattern of association between psychological distress and liver 
disease mortality to be examined. The cohort participants were well characterised, allowing 
relevant contextual variables to be incorporated into the statistical models, although the 
possibility of residual confounding remains. Certain relevant data were unavailable, specifically 
the presence of liver disease or symptoms at baseline, iron status and the subsequent occurrence 
of liver transplantation. Data were missing for one or more variable for 65,464 (39%) of 
participants. However, our complete case analysis reported in supplementary Table 4 suggests 
that there was minimal bias resulting from missing data. 
 
Using GHQ-12 score to estimate psychological distress, although widely used in population 
based studies,16, 21, 22, 26, 27 is not without limitations. The scale itself, with non-specific questions 
about feelings of unhappiness and confidence, worry, and feelings of worthlessness, does not 
provide a clinical diagnosis of anxiety or depression, even though the 12 items do capture several 
aspects of these conditions. However, there is evidence that screening positive on the GHQ-12, 
defined here as scores of 4 or more, is associated with anxiety and depression.25, 40 GHQ-12 has 
been shown to be a valid screening tool for anxiety and depression diagnosed according to the 
Diagnostic and Statistical Manual of Mental Disorders, third edition (revised).41 A further 
limitation is that GHQ-12 score was only recorded at baseline and there was no reassessment of 
psychological distress via questionnaire. 
 
Classifying cause of death according to death certification is a common methodology in 
epidemiological studies.26, 42-46 In this study we have included all cases of liver disease contributing 
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to death, not just those defined as the underlying cause of death. Since causes of death are based 
on the certifying doctor’s clinical assessment and knowledge of the deceased person, the use of 
this broad classification assists in capturing all deaths where liver disease played a role. Given 
that NAFLD is a diagnosis of exclusion and its natural history remains not fully understood it is 
rarely coded in clinical practice on death certificates in the way that disease such as CVD or 
diabetes mellitus are. As a result the only way to identify NAFLD deaths is to create a probable 
group based on the exclusion of all known liver disease diagnoses. This is likely to underestimate 
the number of NAFLD-related deaths since it often does not exist in isolation but in 
combination with ALD or other diagnoses. Furthermore, in these cases, liver disease may not 
have been coded on the death certificate at all. There were insufficient numbers of deaths related 
to other causes of liver disease (e.g. viral hepatitis, haemachromatosis) to allow detailed analysis. 
 
Public health implications and future research directions  
Since this study is the first to identify this association, further work is required to confirm and 
build on the findings of the present study. Future work may involve Mendelian randomisation,47 
perhaps using a polygenic risk score for depression,48, 49 to shed light on the mechanism 
underlying the identified relationship between psychological distress and liver disease mortality. 
The next step would be an aetiological trial exploring the effect of treatment of psychological 
distress (talking therapy and/or medication) on liver function. This has already been done in the 
context of CVD outcomes.50 
 
Conclusion 
In conclusion, we add to the growing evidence of a detrimental impact of psychological distress 
on physical conditions by showing a new relationship with liver disease mortality. The raised risk 
evident at lower levels of distress which are not typically treated by specialists in mental health 
has particular relevance for general health professionals. 
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Table 1. Characteristics of participants according to individual cohort studies: individual participant meta-analysis of sixteen prospective cohort studies 
 
 
  Health Survey for England Scottish Health Survey 
 
  1994 1995 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2008 N 1995 1998 2003 N 
Adults irrespective of consent status N 15804 16055 8582 15908 13947 11025 15647 10331 14836 12758 10303 14142 15102 174440 7932 9040 8092 25064 
Household response % 77 78 76 74 76 75 74 74 73 72 74 68 64 - - 77 67 - 
Consented to mortality linkage % 95.6 93.7 93.9 94.6 90.1 71.9 88.4 88.9 87.3 75.7 80.6 82.6 78.2 - 85.3 86.9 87.9 - 
Included in analytic sample N 14709 14799 7794 14358 11593 7540 13352 8830 12454 8904 7866 11523 11659 145381 6640 7797 6813 21250 
Follow-up duration (years) mean 15.1 14.2 12.6 11.8 11.2 9.4 9.2 8.4 7.4 6.4 5.4 4.5 2.5 145381 13.8 10.6 5.7 21250 
  sd 3.8 3.5 2.8 2.5 1.8 2.7 1.6 1.2 1.1 0.7 0.9 0.6 0.3 - 2.2 2.0 0.9 - 
Deaths from liver disease N  54 42 15 30 6 20 39 11 12 11 9 11 5 145381 52 49 10 21250 
Age at baseline (years) mean 45.8 46.2 46.0 46.5 43.7 51.1 47.1 39.1 47.5 45.2 54.3 49.1 48.7 145381 40.7 45.8 49.8 21250 
  sd 18.5 18.4 18.0 18.3 17.8 20.8 18.0 19.4 17.9 17.6 19.5 18.1 18.3 145381 13.2 15.8 17.6 21250 
Female % 54.2 54.2 54.0 54.7 53.9 55.7 54.7 55.7 55.3 56.0 54.7 55.0 55.2 145381 55.4 56.1 56.1 21250 
GHQ-12 score  mean 1.5 1.7 1.6 1.5 1.7 1.5 1.3 1.6 1.3 1.4 1.2 1.3 1.3 145381 1.7 1.6 1.5 21250 
  sd 2.6 2.7 2.6 2.6 2.8 2.7 2.4 2.6 2.5 2.6 2.4 2.5 2.6 - 2.8 2.8 2.8 - 
Drinks alcohol at least weekly  % 68.6 70.5 72.3 72.7 68.4 69.2 72.1 71.4 71.1 63.8 69.1 68.1 67.4 128154 68.0 68.1 67.5 18869 
Current smoker % 27.3 27.5 28.2 28.0 25.5 24.9 25.4 27.7 24.6 21.5 21.0 22.0 21.5 144946 37.2 34.9 26.4 21120 
Left school ≥16a % 62.3 61.6 63.7 64.6 70.1 63.2 68.4 77.5 70.7 75.9 63.8 72.6 73.7 145293 65.6 61.8 64.5 21233 
Non-manual occupational social class % 54.6 56.0 55.6 55.3 55.4 57.7 58.0 57.8 60.0 60.6 69.6 61.2 61.3 137915 50.5 51.4 56.2 20171 
Body mass index mean 25.9 26.0 26.3 26.4 26.1 26.6 26.9 26.0 26.9 26.7 27.2 27.2 27.5 131570 26.1 26.7 27.4 19023 
  sd 4.5 4.5 4.7 4.7 4.8 4.8 4.9 5.0 5.0 5.0 4.9 5.1 5.1 - 4.6 4.9 5.1 - 
Diabetesb % — 5.0 5.3 2.8 5.4 9.0 6.7 5.6 4.7 5.4 6.7 6.3 8.0 110355 4.0 5.5 5.6 21250 
 
a Leaving school at the age of 16 years of younger approximates to completing only compulsory education, despite the changes in the minimum school leaving age in the UK during the 
twentieth century 
b Comprising doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c, and diabetes hospitalisation 
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Table 2. Characteristics of survey participants included and excluded from analyses: individual participant meta-
analysis of sixteen prospective cohort studies 
 Included Excluded P 
N 166631 32873 - 
Age (mean [SD]) 46.6 (18.4) 50.9 (21.7) <0.001 
Female (%) 45.1 41.9 <0.001 
GHQ-12 score (mean [SD]) 1.5 (2.6) 1.4 (2.6) <0.001 
Drinks alcohol at least weekly (%) 69.5 64.7 <0.001 
Current smoker (%) 26.2 26.7 0.095 
Left school ≥16a (%) 67.5 62.8 <0.001 
Non-manual occupational social class (%) 57.1 51.3 <0.001 
Body mass index (mean [SD]) 26.4 (4.8) 26.4 (5.0) <0.001 
Diabetesb (%) 5.5 7.2 <0.001 
 
a approximates to compulsory education 
b Comprising doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c, and diabetes 
hospitalisation 
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Table 3. Psychological distress score according to baseline characteristics of study members: individual 
participant meta-analysis of sixteen prospective cohort studies 
 Distress score 
 0 1-3 4-6 7-12 
N (%) 98765 (59.3) 42446 (25.5) 13483 (8.1) 11937 (7.2) 
Age (mean [SD]) 47.2 (18.1) 45.7 (19.1) 45.3 (18.9) 47.0 (17.5) 
Female (%) 52.1 56.8 62.3 63.6 
Drinks alcohol at least weekly (%) 63.9 61.2 57.4 53.5 
Current smoker (%) 23.9 26.9 30.8 37.0 
Left school ≥16a (%) 68.4 67.7 66.0 61.3 
Non-manual occupational social class (%) 57.5 58.0 55.9 52.2 
Obeseb (%) 20.5 20.6 21.3 23.6 
Diabetesc (%) 4.9 5.8 6.5 7.4 
 
a approximates to compulsory education 
b Body mass index >30 kg/m2  
c Comprises doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c, and diabetes hospitalisation 
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Table 4. Hazard ratios (95% confidence intervals) for the association between psychological distress (measured by the 12-item General Health Questionnaire) and 
liver disease mortality: individual participant meta-analysis of sixteen prospective cohort studies 
   GHQ-12 score  
Model 
Liver disease 
deaths 
N 0 1-3 4-6 7-12 
Per SD 
disadvantagea 
Ptrend 
Age- and gender-adjusted 
(basic model) 
457 166631 
1 
(Ref.) 
1.18 
(0.93, 1.50) 
2.09 
(1.47, 2.96) 
3.48 
(2.68, 4.52) 
1.40 
(1.31, 1.50) 
<0.001 
+ health behavioursb 451 16471 1 
1.17 
(0.93, 1.49) 
1.96 
(1.37, 2.79) 
3.08 
(2.36, 4.03) 
1.35 
(1.26, 1.45) 
<0.001 
+ socioeconomic statusc 437 158011 1 
1.17 
(0.92, 1.49) 
1.90 
(1.32, 2.73) 
3.52 
(2.70, 4.60) 
1.39 
(1.30, 1.49) 
<0.001 
+ body mass index 403 150593 1 
1.17 
(0.91, 1.50) 
2.21 
(1.53, 3.18) 
3.36 
(2.53, 4.46) 
1.40 
(1.30, 1.50) 
<0.001 
+ diabetesd 339 119520 1 
1.09 
(0.82, 1.45) 
2.04 
(1.37, 3.03) 
3.04 
(2.25, 4.11) 
1.32 
(1.19, 1.46) 
<0.001 
Multivariable adjustede 275 101167 1 
1.02 
(0.75, 1.39) 
2.01 
(1.30, 3.11) 
2.59 
(1.82, 3.68) 
1.26 
(1.13, 1.40) 
<0.001 
Subgroup analyses†         
+ physical activityf 307 114179 1 
1.09 
(0.81, 1.45) 
1.90 
(1.22, 2.95) 
3.11 
(2.27, 4.26) 
1.37 
(1.26, 1.50) 
<0.001 
+ systemic arterial hypertensiong 270 100320 1 
1.37 
(1.00, 1.87) 
2.20 
(1.36, 3.56) 
4.42 
(3.20, 6.11) 
1.50 
(1.38, 1.63) 
<0.001 
+ gamma-GTh 121 21443 1 
1.01 
(0.50, 2.06) 
1.23 
(0.63, 2.42) 
3.06 
(1.91, 4.90) 
1.40 
(1.23, 1.59) 
<0.001 
+ serum cholesteroli 190 64043 1 
1.46 
(0.93, 2.31) 
2.04 
(1.17, 3.57) 
4.27 
(2.87, 6.35) 
1.49 
(1.35, 1.65) 
<0.001 
+ non-HDL cholesterolj 127 46963 1 
1.34 
(0.71, 2.54) 
2.16 
(1.08, 4.32) 
4.83 
(3.03, 7.72) 
1.56 
(1.38, 1.77) 
<0.001 
+ C-reactive protein 78 36270 1 
1.71 
(0.99, 2.96) 
2.77 
(1.03, 7.48) 
4.00 
(2.09, 7.66) 
1.44 
(1.22, 1.71) 
<0.001 
         
 
 
a GHQ-12 score standard deviation = 2.77 (women) and 2.43 (men) 
b Health behaviours comprise frequency of alcohol consumption and smoking 
c Socioeconomic status comprises age upon leaving full-time education and occupational social class 
d Diabetes comprises doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c, and diabetes hospitalisation (not present in HSE 1994) 
e Adjusted for all the variables in the upper half of the table 
f Fewer than five average Weekly Sessions of moderate to vigorous physical activity including domestic (Walk/Domestic 30mins+, Sports/Exercise 15mins+) compared to five or more (UK government recommendations) 
g Systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or on antihypertensive treatment (NICE guidance) 
h Gamma-GT level >51 IU/L vs ≤51 
i Serum total cholesterol >6.2 mmol/L or on lipid-lowering treatment versus other 
j Non-HDL cholesterol (calculated by subtraction of HDL-C from total cholesterol, yielding a measure that encompasses low-, intermediate-, and very-low-density lipoprotein cholesterol)  
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Table 5. Hazard ratios (95% confidence intervals) for the association between psychological distress (measured by the 12-item General Health 
Questionnaire) and liver disease mortality in non-drinkers and those with a normal BMI: individual participant meta-analysis of sixteen prospective 
cohort studies 
   GHQ-12 score  
Model  
Liver disease 
deaths 
0 1-3 4-6 7-12 
Per SD 
disadvantagea 
Ptrend 
Age- and gender-adjusted Full sample (N=166,631) 457 
1 
(Ref.) 
1.18 
(0.93, 1.50) 
2.09 
(1.47, 2.96) 
3.48 
(2.68, 4.52) 
1.40 
(1.31, 1.50) 
<0.001 
 Non-drinkersb (N=11,898) 49 1 
1.90 
(0.87, 4.12) 
6.68 
(1.34, 33.3) 
4.96 
(1.99, 12.3) 
1.48 
(1.16, 1.89) 
0.002 
 Normal BMIc (N=70,600) 176 1 
1.29 
(0.87, 1.90) 
2.46 
(1.32, 4.60) 
4.13 
(2.71, 6.29) 
1.47 
(1.32, 1.64) 
<0.001 
Multivariable adjustedd Full sample (N=101,167) 275 1 
1.02 
(0.75, 1.39) 
2.01 
(1.30, 3.11) 
2.59 
(1.82, 3.68) 
1.26 
(1.13, 1.40) 
<0.001 
 Non-drinkersb,e  (N=6395) 36 1 
1.87 
(0.70, 4.99) 
– 
3.97 
(1.28, 12.3) 
1.37 
(1.00, 1.88) 
0.052 
 Normal BMIc,f (N=47,838) 123 1 
1.37 
(0.86, 2.16) 
2.58 
(1.16, 5.76) 
2.88 
(1.68, 4.93) 
1.32 
(1.15, 1.51) 
<0.001 
         
 
 
a GHQ-12 score standard deviation = 2.77 (women) and 2.43 (men) 
b Non-drinkers defined as currently consuming no alcohol (based on self-report) 
c Body mass index >18.5kg/m2 and <25kg/m2 
d Model adjusted for frequency of alcohol consumption, smoking, age upon leaving full-time education, occupational social class, body mass index, and diabetes (comprising doctor-diagnosed diabetes, longstanding illness 
(diabetes), HbA1c, and diabetes hospitalisation) 
e Model adjusted for all variables in multivariable adjusted model apart from frequency of alcohol consumption 
f Model adjusted for all variables in multivariable adjusted model apart from body mass index 
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Figure 1. Numbers of study members from induction through to analytic sample and 
subsequent mortality: individual participant meta-analysis of sixteen prospective cohort studies 
 
ALD = Alcoholic liver disease; NAFLD = probable non-alcoholic fatty liver disease 
 
 24 
Figure 2. Multivariable-adjusted hazard ratios (95% confidence intervals) for the association 
between increasing levels of psychological distress and liver disease mortality: individual 
participant meta-analysis of sixteen prospective cohort studies 
 
 
